NCT06322420Active, not recruiting
Behavioral Activation for Depression and Habitual Rumination
Mood-reactive Habitual Rumination and Changes During Behavioral Activation Treatment for Major Depression
Source: ClinicalTrials.gov · Last updated 26 Jun 2026
Brief summary (registry, in English)
Depressive rumination, a negative thinking style characterized by repetitive and passive thoughts about the causes, meanings, and consequences of one's feelings and distress, is often described as being a habitual response tendency that forms a vulnerability to depression. Behavioural Activation (BA) is an effective treatment for depression but little is known of mechanisms of changes during a successful treatment completion and for whom the treatment benefits the most. The main purpose of the study is to investigate whether habit-like mood-reactive rumination will change during Behavioral Activation treatment for current depression and mediates symptom changes in the treatment. Important moderators of change will also be investigated (i.e. history of early life stress and cognitive flexibility). We aim to provide individual BA treatment for up to 120 currently depressed participants (from 90 to 120 participants) in 12 treatment sessions over 11 weeks. Measures are obtained at pre-treatment, during treatment, at post-treatment and at 6 month follow up.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- First submitted
- 8 Feb 2024
- Start date
- 9 Feb 2024
- Primary completion date
- 11 Jun 2026
- Lead sponsor
- University of Iceland
- Diseases
- Depression
- NCT number
- NCT06322420
What you commit to
- Study type: Interventional
- Planned participants: 120
- From 9 Feb 2024 to the primary completion date, 11 Jun 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Presence of active and serious suicidal thoughts or a suicidal attempt in the previous 2 months.
- Unstable medical treatment for depression (type of drug and/or dosing) during past two months at pre-treatment assessment.
Other illness
- Current or past psychotic disorders according to the DSM-5 diagnostic criteria evaluated with the DIAMOND diagnostic interview.
- Cognitive impairments or severe physical illness.
Other
- Current or past manic or hypomanic episodes according to the DSM-5 diagnostic criteria evaluated with the DIAMOND diagnostic interview.
- Presence of substance abuse within the last 12 months according to the DSM-5 diagnostic criteria evaluated with the DIAMOND diagnostic interview.
- Recent psychotherapy within the past month at pre-treatment assessment or active psychotherapy during study participation.
Who the study is looking for
- Current major depressive episode according to the DSM-5 diagnostic criteria evaluated with the DIAMOND diagnostic interview, that is considered to be the primary diagnosis.
- Sore of 14 or higher on Becks Depression Inventory-II (BDI-II) that measures severity of symptoms of depression past 2 weeks.
- Participants are between 18 and 65 years of age at start of study.
- Satisfactory understanding of the Icelandic language to complete measures in the study.
- Completion of pre-treatment assessment that includes 2 visits to researchers and a 6-day ecological momentary assessment.
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Iceland Coordinator of this site? Confirm its status | Reykjavik | Iceland | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.